Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease

Cancer Control

Volumn 21, Issue 4, 2014, Pages 313-321

  Deaver, Darcie ^a,c   Horna, Pedro ^a   Cualing, Hernani ^b   Sokol, Lubomir ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b IHCFLOW   (United States)

^c CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; GLUCOCORTICOID; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ARTICLE; CD8+ T LYMPHOCYTE; CERVICAL LYMPHADENOPATHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; EPSTEIN BARR VIRUS INFECTION; ERYTHROCYTE SEDIMENTATION RATE; FEVER; HEADACHE; HERPES VIRUS INFECTION; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOHISTOCHEMISTRY; KIKUCHI DISEASE; LEUKOPENIA; LYMPH NODE BIOPSY; NIGHT SWEAT; PARVOVIRUS INFECTION; PLASMACYTOID DENDRITIC CELL; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; RECURRENCE RISK; SYSTEMIC LUPUS ERYTHEMATOSUS;

HISTIOCYTIC NECROTIZING LYMPHADENITIS; HUMANS;

EID: 84907812236     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327481402100407     Document Type: Article

References (69)

1. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytosis. Nippon Ketsueki Gakkai Zasshi. 1972;35:379-380.
2. Fujimoto Y, Kojima Y, Yamaguchi K. Cervical subacute necrotizing lymphadenitis. New Clinicopathol Ent. 1972;20:920-927.
3. Pileri S, Kikuchi M, Helbron D, et al. Histiocytic necrotizing lymphadenitis without granulocytic infiltration. Virchows Arch A Pathol Anat Histol. 1982;395(3):257-271.
4. Dorfman RF. Histiocytic necrotizing lymphadenitis of Kikuchi and Fujimoto. Arch Pathol Lab Med. 1987;111(11):1026-1029.
5. Lee BC, Patel R. Kikuchi-Fujimoto disease: a 15-year analysis at a children’s hospital in the United States. Clin Pediatr. 2013;52(1):92-95.
6. Vassilakopoulos TP, Pangalis GA, Siakantaris MP, et al. Kikuchi’s lymphadenopathy: a relatively rare but important cause of lymphadenopathy in Greece, potentially associated with the antiphospholipid syndrome. Rheumatol Int. 2010;30(7):925-932.
7. Onciu M, Medeiros LJ. Kikuchi-Fujimoto lymphadenitis. Adv Anat Pathol. 2003;10(4):204-211.
8. Kim TY, Ha KS, Kim Y, et al. Characteristics of Kikuchi-Fujimoto disease in children compared with adults. Eur J Pediatr. 2013;173(1):111-116.
9. Seo JH, Kang JM, Lee H, et al. Histiocytic necrotizing lymphadenitis in children: a clinical and immunohistochemical comparative study with adult patients. Int J Pediatr Otorhinolaryngol. 2013;77(3):429-433.
10. Deaver D, Naghashpour M, Sokol L. Kikuchi-Fujimoto disease in the United States: three case reports and review of the literature [Erratum appears in Mediterr J Hematol Infect Dis. 2014;6(1):E2014023]. Mediterr J Hematol Infect Dis. 2014;6(1):e2014001.
11. Ohta K, Endo N, Kaizaki Y. Axillary and intramammary lymphadenopathy caused by Kikuchi-Fujimoto disease mimicking malignant lymphoma. Breast Cancer. 2013;20(1):97-101.
12. Cunha BA, Mickail N, Durie N, et al. Fever of unknown origin (FUO) caused by Kikuchi’s disease mimicking lymphoma. Heart Lung. 2009;38(5): 450-456.
13. Lee DH, Lee JH, Shim EJ, et al. Disseminated Kikuchi-Fujimoto disease mimicking malignant lymphoma on positron emission tomography in a child. J Pediatr Hematol Oncol. 2009;31(9):687-689.
14. Sarantopoulos GP, Palla B, Said J, et al. Mimics of cutaneous lymphoma: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol. 2013;139(4):536-551.
15. Patra A, Bhattacharya SK. SLE developing in a follow-up patient of Kikuchi’s disease: a rare disorder. J Clin Diagn Res. 2013;7(4):752-753.
16. Mart ínez-Vázquez C, Hughes G, Bordon J, et al. Histiocytic necrotizing lymphadenitis, Kikuchi-Fujimoto’s disease, associated with systemic lupus erythemotosus. QJM. 1997;90(8):531-533.
17. Stasiuk A, Teschke S, Williams GJ, et al. Kikuchi-Fujimoto disease: lymphadenopathy in siblings. CMAJ. 2011;183(1):E58-E60.
18. Tanaka T, Ohmori M, Yasunaga S, et al. DNA typing of HLA class II genes (HLA-DR, -DQ and -DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi’s disease). Tissue Antigens. 1999;54(3):246-253.
19. Cho MS, Choi HJ, Park HK, et al. Questionable role of human herpesviruses in the pathogenesis of Kikuchi disease. Arch Pathol Lab Med. 2007;131(4):604-609.
20. Labrador J, Aparicio MA, Santos-Briz A, et al. Kikuchi-Fujimoto disease: a case supporting a role for human herpesvirus 7 involvement in the pathogenesis. Rheumatol Int. 2013;33(12):3065-3068.
21. Huh J, Kang GH, Gong G, et al. Kaposi’s sarcoma-associated herpesvirus in Kikuchi’s disease. Hum Pathol. 1998;29(10):1091-1096.
22. Zhang WP, Wang JH, Wang WQ, et al. An association between parvovirus B19 and Kikuchi-Fujimoto disease. Viral Immunol. 2007;20(3):421-428.
23. Hudnall SD, Chen T, Amr S, et al. Detection of human herpesvirus DNA in Kikuchi-Fujimoto disease and reactive lymphoid hyperplasia. Int J Clin Exp Pathol. 2008;1(4):362-368.
24. Hollingsworth HC, Peiper SC, Weiss LM, et al. An investigation of the viral pathogenesis of Kikuchi-Fujimoto disease. Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents. Arch Pathol Lab Med. 1994;118(2):134-140.
25. Yen A, Fearneyhough P, Raimer SS, et al. EBV-associated Kikuchi’s histiocytic necrotizing lymphadenitis with cutaneous manifestations. J Am Acad Dermatol. 1997;36(2 pt 2):342-346.
26. Chiu CF, Chow KC, Lin TY, et al. Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan. Detection of Epstein-Barr virus, type I human T-cell lymphotropic virus, and parvovirus B19. Am J Clin Pathol. 2000;113(6):774-781.
27. Bosch X, Guilabert A, Miquel R, et al. Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol. 2004;122(1):141-152.
28. Khanna D, Shrivastava A, Malur PR, et al. Necrotizing lymphadenitis in systemic lupus erythematosus: is it Kikuchi-Fujimoto disease? J Clin Rheumatol. 2010;16(3):123-124.
29. American College of Rheumatology. 1997 update of revised systemic lupus erythematosus. www.rheumatology.org/Practice/Clinical/Classification/SLE/1997_Update_of_Revised_Systemic_Lupus_Erythematosus/. Accessed August 6, 2014.
30. Sope ña B, Rivera A, Vázquez-Triñanes C, et al. Autoimmune manifestations of Kikuchi disease. Semin Arthritis Rheum. 2012;41(6):900-906.
31. Kim SK, Kang MS, Yoon BY, et al. Histiocytic necrotizing lymphadenitis in the context of systemic lupus erythematosus (SLE): is histiocytic necrotizing lymphadenitis in SLE associated with skin lesions? Lupus. 2011;20(8):809-819.
32. Kucukardali Y, Solmazgul E, Kunter E, et al. Kikuchi-Fujimoto disease: analysis of 244 cases. Clin Rheumatol. 2007;26(1):50-54.
33. Paradela S, Lorenzo J, Martínez-Gómez W, et al. Interface dermatitis in skin lesions of Kikuchi-Fujimoto’s disease: a histopathological marker of evolution into systemic lupus erythematosus? Lupus. 2008;17(12):1127-1135.
34. Dorfman RF, Berry GJ. Kikuchi’s hisiocytic necrotizing lymphadenitis: an analysis of 108 cases with emphasis on differential diagnosis. Semin Diag Pathol. 1988;5(4):329-345.
35. Smith LW, Gelber AC, Petri M. Diffuse lymphadenopathy as the presenting manifestation of systemic lupus erythematosus. J Clin Rheumatol. 2013;19(7);397-399.
36. Ishimura M, Yamamoto H, Mizuno Y, et al. A non-invasive diagnosis of histiocytic necrotizing lymphadenitis by means of gene expression profile analysis of peripheral blood mononuclear cells. J Clin Immunol. 2013;33(5):1018-1026.
37. Ohshima K, Karube K, Hamasaki M, et al. Apoptosis- and cell cycle-associated gene expression profiling of histiocytic necrotising lymphadenitis. Eur J Haematol. 2004;72(5):322-329.
38. Ohshima K, Haraoka S, Takahata Y, et al. Interferon-gamma, interleukin-18, monokine induced by interferon-gamma and interferon-gamma-inducible protein-10 in histiocytic necrotizing lymphadenitis. Leuk Lymphoma. 2002;43(5):1115-20.
39. Tsang WY, Chan JK, Ng CS. Kichuchi’s lymphadenitis. A morphologic analysis of 75 cases with special reference to unusual features. Am J Surg Pathol. 1994;18(3):219-231.
40. Lin HC, Su CY, Huang CC, et al. Kikuchi’s disease: a review and analysis of 61 cases. Otolaryngol Head Neck Surg. 2003;128(5):650-653.
41. Cheng CY, Sheng WH, Lo YC, et al. Clinical presentations, laboratory results and outcomes of patients with Kikuchi’s disease: emphasis on the association between recurrent Kikuchi’s disease and autoimmune diseases. J Microbiol Immunol Infect. 2010;43(5):366-371.
42. Seno A, Torigoe R, Shimoe K, et al. Kikuchi’s disease (histiocytic necrotizing lymphadenitis) with cutaneous involvement. J Am Acad Derm. 1994;30(3):504-506.
43. Atwater AR, Longley BJ, Aughenbaugh WD. Kikuchi’s disease: case report and systematic review of cutaneous and histopathologic presentations. J Am Acad Dermatol. 2008;59(1):130-136.
44. Galor A, Georgy M, Leder HA, et al. Papillary conjunctivitis associated with Kikuchi disease. Cornea. 2008;27(8):944-946.
45. Lim GY, Cho B, Chung NG. Hemophagocytic lymphohistiocytosis preceded by Kikuchi disease in children. Pediatr Radiol. 2008;38(7):756-761.
46. Sato Y, Kuno H, Oizumi K. Histiocytic necrotizing lymphadenitis (Kikuchi’s disease) with aseptic meningitis. J Neurol Sci. 1999;163(2):187-191.
47. Moon JS, Il Kim G, Koo YH, et al. Kinetic tremor and cerebellar ataxia as initial manifestations of Kikuchi-Fujimoto’s disease. J Neurol Sci. 2009;277(1-2):181-183.
48. Douglas M, Bradbury R, Kannangara S, et al. Arthritis as an unusual manifestation of Kikuchi-Fujimoto disease. Rheumatology (Oxford). 2003;42(8):1010-1012.
49. Chan JK, Wong KC, Ng CS. A fatal case of multicentric Kikuchi’s histiocytic necrotizing lymphadenitis. Cancer. 1989;63(9):1856-1862.
50. Kuo TT. Kikuchi’s disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy. Am J Surg Pathol. 1995;19(7):798-809.
51. Tong T, Chan O, Lee K. Diagnosing Kikuchi disease on fine needle aspiration biopsy: a retrospective study of 44 cases diagnosed by cytology and 8 by histotopathology. Acta Cytol. 2001;45:953-957.
52. Das DK, Mallik MK, Dashti HA, et al. Kikuchi-Fujimoto disease in fine-needle aspiration smears: a clinico-cytologic study of 76 cases of KFD and 684 cases of reactive hyperplasia of the lymph node. Diagn Cytopathol. 2013;41(4):288-295.
53. Gordon JK, Magro C, Lu T, et al. Overlap between systemic lupus erythematosus and Kikuchi Fujimoto disease: a clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery. HSS J. 2009;5(2):169-177.
54. Menasce LP, Banerjee SS, Edmondson D, et al. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): continuing diagnostic difficulties. Histopathology. 1998;33(3):248-254.
55. Melikoglu M., Melikoglu M. The clinical importance of lymphadenopathy in systemic lupus erythematosus. Acta Reumatol Port. 2008;33(4):402-406.
56. Lee, S, Yoo JH, Lee SW. Kikuchi disease: differentiation from tuberculous lymphadenitis based on patterns of nodal necrosis on CT. AJNR Am J Neuroradiol. 2012;33(1):135-140.
57. Tsujikawa T, Tsuchida T, Imamura Y, et al. Kikuchi-Fujimot disease: PET/CT assessment of a rare cause of cervical lymphadenopathy. Clin Nucl Med. 2011;36(8):661-664.
58. Lo WC, Chang WC, Lin YC, et al. Ultrasonographic differentiation between Kikuchi’s disease and lymphoma in patients with cervical lymphadenopathy. Eur J Radiol. 2012;81(8):1817-1820.
59. Chen PH, Huang YF, Tang CW, et al. Kikuchi-Fujimoto disease: an amazing response to hydroxychloroquine. Eur J Pediatr. 2010;169(12): 1557-1559.
60. Yoshioka K, Miyashita T, Nakamura T, et al. Treatment of histiocytic necrotizing lymphadenisis (Kikuchi’s disease) with prolonged fever by a single course of methylprednisolone pulse therapy without maintenance therapy: experience with 13 cases. Intern Med. 2010;49(20):2267-2270.
61. Rezai K, Kuchipudi S, Chundi V, et al B. Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment. Clin Infect Dis. 2004;39:e124-e126.
62. Yalcin S, Toprak SK, Erismis B, et al. Management of Kikuchi-Fujimoto disease using glucocorticoid: a case report. Case Rep Med. 2011;2011:230840.
63. Rezayat T, Carroll MB, Ramsey BC, et al. A case of relapsing Kikuchi-Fujimoto disease. Case Rep Otolaryngol. 2013;2013:364795.
64. Bogusz AM, Bhargava P. Recurrent histiocytic necrotizing lymphadenitis with a long latency in a patient with autoimmunity: a case report and review of literature. Int J Surg Pathol. 2013;21(3):287-296.
65. Altuntas F, Sari I, Canoz O, et al. Kikuchi-Fujimoto disease: a rare but important cause of fever and lymphadenopathy in pregnant women. Am J Hematol. 2006;81(2):118-120.
66. Dubois RE, Bondell S, Krissman PH. Kikuchi-Fujimoto syndrome during pregnancy. South Med J. 1991;84(8):1029-1030.
67. Alijotas RJ, Casellas CM, Ferrer Oliveras R, et al. Recurrent Kikuchi-Fujimoto disease during pregnancy: report of case evolving into systemic lupus erythematosus and review of published work. J Obstet Gynaecol Res. 2008;34(4 pt 2):595-598.
68. Kampitak T. Fatal Kikuchi-Fujimoto disease associated with SLE and hemophagocytic syndrome: a case report. Clin Rheumatol. 2008;27(8):1073-1075.
69. Quint ás-Cardama A, Fraga M, Cozzi SN, et al. Fatal Kikuchi-Fujimoto disease: the lupus connection [Erratum appears in Ann Hematol. 2003;82(6):377]. Ann Hematol. 2003;82(3):186-188.